Featured Research

from universities, journals, and other organizations

Increasing need for rehabilitation for eye disease

Date:
January 11, 2012
Source:
Deutsches Aerzteblatt International
Summary:
Visual rehabilitation will continue to increase in importance in the near future, particularly because the number of older patients is rising, new research shows.

Visual rehabilitation will continue to increase in importance in the near future, particularly because the number of older patients is rising. Susanne Trauzettel-Klosinski summarizes the present state of knowledge in the current issue of the Deutsches Δrzteblatt International.

Diseases of the eyes and visual pathways can lead to various impairments in everyday living and require specific rehabilitation. For example, central deficits in the visual field disturb the ability to read, while peripheral deficits make it difficult to orientate oneself. Age-related macular degeneration is the most common cause of severe visual impairment in the industrialized nations.

The numbers of patients suffering stroke and consequent visual impairment is also set to rise. For most patients, careful diagnosis of the visual impairment and analysis of its effects allow reading ability to be restored and self-orientation improved through appropriate rehabilitation techniques, thus increasing independence and quality of life. Visual rehabilitation goes well beyond the purely optical.

Spontaneous adaptation strategies are supported and training given in compensatory behaviors. A variety of visual aids are available for this. In addition, reading speed can be improved by specific reading training, and impaired orientation improved by tactile aids such as the long cane and progressive training.


Story Source:

The above story is based on materials provided by Deutsches Aerzteblatt International. Note: Materials may be edited for content and length.


Journal Reference:

  1. Trauzettel-Klosinski S. Current methods of visual rehabilitation. Dtsch Arztebl Int, 2011; 108(51%u201352): 871%u20138 DOI: 10.3238/arztebl.2011.0871

Cite This Page:

Deutsches Aerzteblatt International. "Increasing need for rehabilitation for eye disease." ScienceDaily. ScienceDaily, 11 January 2012. <www.sciencedaily.com/releases/2012/01/120111103752.htm>.
Deutsches Aerzteblatt International. (2012, January 11). Increasing need for rehabilitation for eye disease. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2012/01/120111103752.htm
Deutsches Aerzteblatt International. "Increasing need for rehabilitation for eye disease." ScienceDaily. www.sciencedaily.com/releases/2012/01/120111103752.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) — Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) — The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) — Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins